2000
DOI: 10.1523/jneurosci.20-24-08965.2000
|View full text |Cite
|
Sign up to set email alerts
|

Induction of Cyclin-Dependent Kinase 5 in the Hippocampus by Chronic Electroconvulsive Seizures: Role of ΔFosB

Abstract: The transcription factor DeltaFosB is induced in the hippocampus and other brain regions by repeated electroconvulsive seizures (ECS), an effective antidepressant treatment. The unusually high stability of this protein makes it an attractive candidate to mediate some of the long-lasting changes in the brain caused by ECS treatment. To understand how DeltaFosB might alter brain function, we examined the gene expression profiles in the hippocampus of inducible transgenic mice that express DeltaFosB in this brain… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
100
1

Year Published

2003
2003
2015
2015

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 104 publications
(102 citation statements)
references
References 38 publications
1
100
1
Order By: Relevance
“…This approach has led to the identification of many genes that are up-or downregulated by DFosB expression in this brain region (Chen et al 2000(Chen et al , 2003Ang et al 2001;McClung & Nestler 2003). Two genes that appear to be induced through DFosB's actions as a transcriptional activator are cyclin-dependent kinase-5 (Cdk5) and its cofactor P35 (Bibb et al 2001;McClung & Nestler 2003).…”
Section: Target Genes For Dfosb In Nucleus Accumbensmentioning
confidence: 99%
See 1 more Smart Citation
“…This approach has led to the identification of many genes that are up-or downregulated by DFosB expression in this brain region (Chen et al 2000(Chen et al , 2003Ang et al 2001;McClung & Nestler 2003). Two genes that appear to be induced through DFosB's actions as a transcriptional activator are cyclin-dependent kinase-5 (Cdk5) and its cofactor P35 (Bibb et al 2001;McClung & Nestler 2003).…”
Section: Target Genes For Dfosb In Nucleus Accumbensmentioning
confidence: 99%
“…Two genes that appear to be induced through DFosB's actions as a transcriptional activator are cyclin-dependent kinase-5 (Cdk5) and its cofactor P35 (Bibb et al 2001;McClung & Nestler 2003). Cdk5 is also induced by chronic cocaine in the nucleus accumbens, an effect blocked upon DcJun expression, and DFosB binds to and activates the Cdk5 gene through an AP-1 site in its promoter (Chen et al 2000;Peakman et al 2003). Cdk5 is an important target of DFosB since its expression has been directly linked to changes in the phosphorylation state of numerous synaptic proteins including glutamate receptor subunits (Bibb et al 2001), as well as increases in dendritic spine density (Norrholm et al 2003;Lee et al 2006), in the nucleus accumbens, which are associated with chronic cocaine administration (Robinson & Kolb 2004).…”
Section: Target Genes For Dfosb In Nucleus Accumbensmentioning
confidence: 99%
“…Therefore, identification of the target genes that are regulated by ⌬FosB induction is expected to contribute to a greater understanding of the molecular mechanism underlying cocaine addiction. Recently, chronic treatment of animals with cocaine has been shown to up-regulate the expression of cyclin-dependent kinase 5 (Cdk5) and its activator p35 in the striatum through the induction of ⌬FosB (6,7).…”
mentioning
confidence: 99%
“…DFosB is an alternatively spliced variant of the fosB gene. Like c-Fos, DFosB forms heterodimers with Jun proteins, mainly JunD, to form active activator protein-1 (AP-1) complexes, which then bind to AP-1 sites in the promoter regions of many neural genes (Chen et al, 2000). DFosB lacks a portion of the C-terminus, which is the major transactivation domain of full-length FosB (Nakabeppu et al, 1993).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, DFosB may be a weak transcriptional activator and in some cases may function as a transcriptional repressor (Nakabeppu and Nathans, 1991). Several downstream target genes for DFosB have been identified to date, including NMDAR1, GluR2, cyclin-dependent kinase-5 (Cdk5), and NF-kB (Hiroi et al, 1998;Kelz et al, 1999;Chen et al, 2000;Ang et al, 2001).…”
Section: Introductionmentioning
confidence: 99%